Literature DB >> 20468062

In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study.

Janet K Williams1, Cheryl Erwin, Andrew R Juhl, Michelle Mengeling, Yvonne Bombard, Michael R Hayden, Kimberly Quaid, Ira Shoulson, Sandra Taylor, Jane S Paulsen.   

Abstract

Genetic discrimination may be experienced in the day-to-day lives of people at risk for Huntington disease (HD), encompassing occurrences in the workplace, when seeking insurance, within social relationships, and during other daily encounters. At-risk individuals who have tested either positive or negative for the genetic expansion that causes HD, as well as at-risk persons with a 50% chance for developing the disorder but have not had DNA testing completed the International RESPOND-HD (I-RESPOND-HD) survey. One of the study's purposes was to examine perceptions of genetic stigmatization and discrimination. A total of 412 out of 433 participants provided narrative comments, and 191 provided related codable narrative data. The core theme, Information Control, refers to organizational policies and interpersonal actions. This theme was found in narrative comments describing genetic discrimination perceptions across employment, insurance, social, and other situations. These reports were elaborated with five themes: What They Encountered, What They Felt, What Others Did, What They Did, and What Happened. Although many perceptions were coded as hurtful, this was not true in all instances. Findings document that reports of genetic discrimination are highly individual, and both policy as well as interpersonal factors contribute to the outcome of potentially discriminating events. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20468062      PMCID: PMC3035936          DOI: 10.1002/ajmg.b.31080

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  21 in total

1.  Clinical markers of early disease in persons near onset of Huntington's disease.

Authors:  J S Paulsen; H Zhao; J C Stout; R R Brinkman; M Guttman; C A Ross; P Como; C Manning; M R Hayden; I Shoulson
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

2.  Is there a pink slip in my gene? Genetic discrimination in the workplace.

Authors:  P S Miller
Journal:  J Health Care Law Policy       Date:  2000

Review 3.  Uncommon dementia and the carer's perspective.

Authors:  D LoGiudice; A Hassett
Journal:  Int Psychogeriatr       Date:  2005       Impact factor: 3.878

4.  Managing and analyzing qualitative data. A description of tasks, techniques, and materials.

Authors:  K A Knafl; D C Webster
Journal:  West J Nurs Res       Date:  1988-04       Impact factor: 1.967

5.  At risk for Huntington disease: The PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled.

Authors: 
Journal:  Arch Neurol       Date:  2006-07

6.  Preparing for preventive clinical trials: the Predict-HD study.

Authors:  Jane S Paulsen; Michael Hayden; Julie C Stout; Douglas R Langbehn; Elizabeth Aylward; Christopher A Ross; Mark Guttman; Martha Nance; Karl Kieburtz; David Oakes; Ira Shoulson; Elise Kayson; Shannon Johnson; Elizabeth Penziner
Journal:  Arch Neurol       Date:  2006-06

7.  Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study.

Authors:  Cheryl Erwin; Janet K Williams; Andrew R Juhl; Michelle Mengeling; James A Mills; Yvonne Bombard; Michael R Hayden; Kimberly Quaid; Ira Shoulson; Sandra Taylor; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

8.  Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutation.

Authors:  Y Bombard; E Penziner; J Decolongon; M L N Klimek; S Creighton; O Suchowersky; M Guttman; J S Paulsen; J L Bottorff; M R Hayden
Journal:  Clin Genet       Date:  2007-03       Impact factor: 4.438

9.  Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease.

Authors:  Yvonne Bombard; Elizabeth Penziner; Oksana Suchowersky; Mark Guttman; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2007-10-24       Impact factor: 4.246

10.  Fear of health insurance loss among individuals at risk for Huntington disease.

Authors:  Emily Oster; E Ray Dorsey; Jan Bausch; Aileen Shinaman; Elise Kayson; David Oakes; Ira Shoulson; Kimberly Quaid
Journal:  Am J Med Genet A       Date:  2008-08-15       Impact factor: 2.802

View more
  17 in total

1.  Personal factors associated with reported benefits of Huntington disease family history or genetic testing.

Authors:  Janet K Williams; Cheryl Erwin; Andrew Juhl; James Mills; Bradley Brossman; Jane S Paulsen
Journal:  Genet Test Mol Biomarkers       Date:  2010-08-19

2.  New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system).

Authors:  N E Carlozzi; N R Downing; M K McCormack; S G Schilling; J S Perlmutter; E A Hahn; J S Lai; S Frank; K A Quaid; J S Paulsen; D Cella; S M Goodnight; J A Miner; M A Nance
Journal:  Qual Life Res       Date:  2016-07-08       Impact factor: 4.147

3.  Perceived stress in prodromal Huntington disease.

Authors:  Nancy Downing; Megan M Smith; Leigh J Beglinger; James Mills; Kevin Duff; Kelly C Rowe; Eric Epping; Jane S Paulsen
Journal:  Psychol Health       Date:  2011-06-21

Review 4.  Therapeutic approaches to Huntington disease: from the bench to the clinic.

Authors:  Nicholas S Caron; E Ray Dorsey; Michael R Hayden
Journal:  Nat Rev Drug Discov       Date:  2018-09-21       Impact factor: 84.694

5.  Onset of Huntington's disease: can it be purely cognitive?

Authors:  Jane S Paulsen; Jeffrey D Long
Journal:  Mov Disord       Date:  2014-08-20       Impact factor: 10.338

6.  The Effect of Predictive Testing in Adult-Onset Neurodegenerative Diseases on Social and Personal Life.

Authors:  Petra E Cohn-Hokke; John C van Swieten; Yolande A L Pijnenburg; Aad Tibben; Hanne Meijers-Heijboer; Anneke Kievit
Journal:  J Genet Couns       Date:  2017-12-21       Impact factor: 2.537

7.  Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians.

Authors:  Carey Wexler Sherman; Ravi Iyer; Victor Abler; Alexandria Antonelli; Noelle E Carlozzi
Journal:  Neuropsychol Rehabil       Date:  2019-03-08       Impact factor: 2.868

8.  Analysis of the Reasons for Non-Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative Study.

Authors:  Jesús Rivera-Navarro; Esther Cubo; Natividad Mariscal
Journal:  J Genet Couns       Date:  2015-04-30       Impact factor: 2.537

9.  Attitudes of patients with cancer about personalized medicine and somatic genetic testing.

Authors:  Stacy W Gray; Katherine Hicks-Courant; Christopher S Lathan; Levi Garraway; Elyse R Park; Jane C Weeks
Journal:  J Oncol Pract       Date:  2012-08-07       Impact factor: 3.840

10.  Perception, experience, and response to genetic discrimination in Huntington's disease: the Australian results of The International RESPOND-HD study.

Authors:  Anita M Y Goh; Edmond Chiu; Olga Yastrubetskaya; Cheryl Erwin; Janet K Williams; Andrew R Juhl; Jane S Paulsen
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.